<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hyperosmolar agents are a primary therapeutic modality employed in the treatment of traumatic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Profound hyperosmolarity accompanied by systemic <z:hpo ids='HP_0001944'>dehydration</z:hpo> is a potentially serious problem when these drugs are used repeatedly for control of intracranial pressure </plain></SENT>
<SENT sid="2" pm="."><plain>Because <z:chebi fb="3" ids="17754">glycerol</z:chebi>, a water-soluble alcohol, is metabolized in the liver, its dehydrating capacity may be reduced in comparison to other agents </plain></SENT>
<SENT sid="3" pm="."><plain>A series of 15 patients were treated with oral <z:chebi fb="3" ids="17754">glycerol</z:chebi> (0.5 to 1.0 gm/kg) with only minor changes in serum electrolytes, <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:chebi fb="20" ids="16199">urea</z:chebi> nitrogen </plain></SENT>
<SENT sid="4" pm="."><plain>Serum osmolarity rose from a baseline of 305 mOsm/liter to 355 mOsm/liter after 10 days of therapy </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="3" ids="17754">Glycerol</z:chebi> was found to be effective and safe when employed in this protocol and proved to be a valuable adjunct to the standard methods available for control of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
</text></document>